Form D · Biotechnology
Guardian Therapeutics, LLC
Cambridge, MA · CIK 0001730977
Offering snapshot reported Aug 15, 2018 · SEC filing
- Reported sold
- $20M Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 13, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 15, 2018 | Initial | $20,000,000 | No comparison | 1 | SEC filing |
| Feb 12, 2018 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-319299
Source: Form D, filed Aug 15, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Clarke Atwell | Executive |
| James C. Gilbert, Md | Executive |
| Christa Badger Schmidt | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
21 Erie Street
Cambridge, MA, 02139
Cambridge, MA, 02139